Catalyst

Slingshot members are tracking this event:

Relypsa (RLYP) to Present New Analyses on Various Veltassa Trials in Hyperkalemia at National Kidney Foundation 2016 Spring Meeting

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AZN

100%
RLYP

66%
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Veltassa, Hyperkalemia